These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12957639)

  • 1. Pediatric drug formulations of sodium benzoate: I. Coated granules with a hydrophilic binder.
    Breitkreutz J; Bornhöft M; Wöll F; Kleinebudde P
    Eur J Pharm Biopharm; 2003 Sep; 56(2):247-53. PubMed ID: 12957639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric drug formulations of sodium benzoate: II. Coated granules with a lipophilic binder.
    Breitkreutz J; El-Saleh F; Kiera C; Kleinebudde P; Wiedey W
    Eur J Pharm Biopharm; 2003 Sep; 56(2):255-60. PubMed ID: 12957640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric drug formulation of sodium benzoate extended-release granules.
    Combescot E; Morat G; de Lonlay P; Boudy V
    Pharm Dev Technol; 2016; 21(3):261-7. PubMed ID: 25582668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lean production of taste improved lipidic sodium benzoate formulations.
    Eckert C; Pein M; Breitkreutz J
    Eur J Pharm Biopharm; 2014 Oct; 88(2):455-61. PubMed ID: 24859305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and Clinical Evaluation of Sodium Benzoate Oral Solution for the Treatment of Urea Cycle Disorders in Pediatric Patients.
    Maines E; Urru SAM; Burri E; Piccoli G; Pedrolli A; Pasqualini A; Burlina AL; Temporin G
    AAPS PharmSciTech; 2020 Mar; 21(3):100. PubMed ID: 32152836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immediate release pellets with lipid binders obtained by solvent-free cold extrusion.
    Krause J; Thommes M; Breitkreutz J
    Eur J Pharm Biopharm; 2009 Jan; 71(1):138-44. PubMed ID: 18805483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the granule strength of roller-compacted ibuprofen sodium for hot-melt coating processing.
    Lopes DG; Garsuch V; Becker K; Paudel A; Stehr M; Zimmer A; Salar-Behzadi S
    Int J Pharm; 2016 Aug; 510(1):285-95. PubMed ID: 27346416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melt-Extruded Eudragit® FS-Based Granules for Colonic Drug Delivery.
    Zhang F
    AAPS PharmSciTech; 2016 Feb; 17(1):56-67. PubMed ID: 26162974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of Extemporaneously Prepared Sodium Benzoate Oral Suspension.
    Atkins JR; Lull ME; Decker AS; Hutchinson DJ
    Int J Pharm Compd; 2018; 22(4):326-328. PubMed ID: 30021187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of sodium phenylacetate and sodium benzoate following intravenous administration as both a bolus and continuous infusion to healthy adult volunteers.
    MacArthur RB; Altincatal A; Tuchman M
    Mol Genet Metab; 2004 Apr; 81 Suppl 1():S67-73. PubMed ID: 15050977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and characterization of enteric-coated controlled release mucoadhesive microcapsules of Rabeprazole sodium.
    Swain S; Behera UA; Beg S; Sruti J; Patro ChN; Dinda SC; Rao ME
    Drug Dev Ind Pharm; 2013 Apr; 39(4):548-60. PubMed ID: 22512732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro dissolution studies of sodium diclofenac granules coated with Eudragit L-30D-55 by fluidized-bed system.
    Silva OS; Souza CR; Oliveira WP; Rocha SC
    Drug Dev Ind Pharm; 2006 Jul; 32(6):661-7. PubMed ID: 16885121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
    Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
    AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug.
    Lakshman JP; Cao Y; Kowalski J; Serajuddin AT
    Mol Pharm; 2008; 5(6):994-1002. PubMed ID: 19434852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tablet formulation study of spray-dried sodium diclofenac enteric-coated microcapsules.
    Lin SY; Kao YH
    Pharm Res; 1991 Jul; 8(7):919-24. PubMed ID: 1924144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicochemical properties and mechanisms of drug release from melt-extruded granules consisting of chlorpheniramine maleate and Eudragit FS.
    Zhang F
    Drug Dev Ind Pharm; 2016; 42(4):563-71. PubMed ID: 26065535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of coating layer and release medium on release profile from coated capsules with Eudragit FS 30D: an in vitro and in vivo study.
    Moghimipour E; Rezaei M; Kouchak M; Fatahiasl J; Angali KA; Ramezani Z; Amini M; Dorkoosh FA; Handali S
    Drug Dev Ind Pharm; 2018 May; 44(5):861-867. PubMed ID: 29235889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.